Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 222,038,261 papers from all fields of science
Search
Sign In
Create Free Account
WT1 peptide vaccine
Known as:
WT-1 vax
, WT1 Analog Peptide Vaccine
A peptide vaccine comprised of an epitope of human Wilms tumor 1 (WT-1) with potential antineoplastic activity. WT-1, a transcription factor, is…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Antigen Sensitization
Cytotoxic T-Lymphocytes
T-Cell Activation
immunopotentiation
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
WT1 peptide vaccine in Montanide in contrast to poly ICLC, is able to induce WT1-specific immune response with TCR clonal enrichment in myeloid leukemia
Hongtao Liu
,
Y. Zha
,
+10 authors
W. Stock
Experimental Hematology & Oncology
2018
Corpus ID: 38283867
BackgroundThe optimal strategy for vaccination to induce CD8+ T cell responses against WT1 is not known.MethodsA pilot randomized…
Expand
Review
2017
Review
2017
Wilms' Tumor Gene 1 (WT1) Peptide Vaccine Therapy for Hematological Malignancies: From CTL Epitope Identification to Recent Progress in Clinical Studies Including a Cure-Oriented Strategy
Y. Oka
,
A. Tsuboi
,
+5 authors
H. Sugiyama
Oncology Research and Treatment
2017
Corpus ID: 11695115
The identification of human Wilms' tumor gene 1 (WT1) protein-derived cytotoxic T lymphocyte (CTL) epitopes and the in vivo…
Expand
2017
2017
Targeting WT1 in hematologic malignancies?
G. Koehne
Blood
2017
Corpus ID: 206955974
In this issue of Blood, Tawara et al report the first results of a novel treatment approach with T-cell receptor transduced…
Expand
2016
2016
DSP-7888, a Novel Cocktail Design of WT1 Peptide Vaccine, and Its Combinational Immunotherapy with Immune Checkpoint-Blocking Antibody Against PD-1
Masashi Goto
,
Megumi Nakamura
,
+4 authors
C. Li
2016
Corpus ID: 79619682
Background: Wilms9 tumor gene 1 (WT1), broadly expressed in hematological malignancies and solid tumors, is a promising candidate…
Expand
2012
2012
Enhanced tumor immunity of WT1 peptide vaccination by interferon-β administration.
H. Nakajima
,
Y. Oka
,
+13 authors
H. Sugiyama
Vaccine
2012
Corpus ID: 43094507
2006
2006
Clinical and immune responses of WT1-peptide vaccination in patients with acute myeloid leukemia.
U. Keilholz
,
A. Letsch
,
+5 authors
C. Scheibenbogen
Journal of Clinical Oncology
2006
Corpus ID: 26472806
2511 Background: The transcription factor Wilms tumor protein (WT) 1 belongs to a new generation of tumor antigens, as it is…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE